COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS
Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
1 . A composition, comprising a urolithin in the amount of 300-500 mg, 450-750 mg, or 600-1000 mg.
2 . The composition of claim 1 , wherein the amount of the urolithin is 300-500 mg.
3 . The composition of claim 2 , wherein the amount of the urolithin is 500 mg.
4 . The composition of claim 1 , wherein the amount of the urolithin is 450-750 mg.
5 . The composition of claim 1 , wherein the amount of the urolithin is 600-1000 mg.
6 . The composition of claim 5 , wherein the effective amount of the urolithin is 1000 mg.
7 . The composition of claim 1 , wherein the urolithin is selected from the group consisting of urolithin A, urolithin B, and a combination of urolithin A and urolithin B.
8 . The composition of claim 1 , wherein the urolithin is urolithin A.
9 . The composition of claim 2 , wherein the urolithin is urolithin A.
10 . The composition of claim 3 , wherein the urolithin is urolithin A.
11 . The composition of claim 4 , wherein the urolithin is urolithin A.
12 . The composition of claim 5 , wherein the urolithin is urolithin A.
13 . The composition of claim 6 , wherein the urolithin is urolithin A.
14 . The composition of claim 1 , wherein the composition is in the form of a medical food.
15 . The composition of claim 1 , wherein the composition is in the form of a functional food.
16 . The composition of claim 1 , wherein the composition is in the form of a food additive.
17 . The composition of claim 1 , wherein the composition is in the form of a dietary supplement.
18 . The composition of claim 1 , wherein the composition is in the form of a food product.
19 . The composition of claim 1 , wherein the composition is formulated for oral administration.